Zymeworks Inc.
Current role
ZYME
Dr. Jeffrey Smith
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Jeffrey Smith
Zymeworks Inc. reported in an 8-K filed January 4, 2023 that Dr. Jeffrey Smith was appointed SVP, Early-Stage Development.
“The early-stage development group will be led by newly appointed SVP, Early-Stage Development, Dr. Jeffrey Smith, to be based in the Company's Dublin offices.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Zymeworks Inc. (ZYME)
SEC 8-K
Current2023-01-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Zymeworks Inc.
Other people whose current roles at this company are on record from its filings.
- Ali Tehrani CEO
- Kenneth Galbraith CEO, CFO
- Kristin Stafford CFO
- Leone Patterson CFO
- Mark Hollywood COO
- Scott Platshon CIO, Board Member
- Alessandra Cesano Board Member
- Brian Cherry Board Member
- Carlos Campoy Board Member
- Derek Miller Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.